CEMIP and cancer: Increased expression of KIAA1199 has been reported in a number of clinical conditions e.g. in patients with different cancer types12,14,16,17 and in patients with rheumatoid arthritis and osteoarthritis, both conditions are characterized by joint inflammation21–24.